Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

The Combination Therapy of Hypertension to Prevent Cardiovascular Events Trial.

Next Previous
Trial Profile

The Combination Therapy of Hypertension to Prevent Cardiovascular Events Trial.

Status: Completed
Phase of Trial: Phase IV

Latest Information Update: 08 Sep 2017

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Benidipine (Primary) ; Angiotensin receptor antagonists; Beta adrenergic receptor antagonists; Thiazide diuretics
  • Indications Cardiovascular disorders; Hypertension
  • Focus Adverse reactions; Therapeutic Use
  • Acronyms COPE
  • Sponsors Kyowa Hakko Kogyo

Most Recent Events

  • 02 Sep 2017 Results (n=3293) of prespecified subanalysis of COPE trial published in the Circulation Journal
  • 21 Feb 2012 Actual end date changed from Sep 2010 to Nov 2010 as reported by ClinicalTrials.gov.
  • 21 Feb 2012 Official title amended as reported by ClinicalTrials.gov.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top